Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced preliminary, unaudited revenue results for the ...

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has ...

Welcome to Inogen’s Fourth Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. Following management’s prepared remarks, we will hold a Q&A session.

Inogen, Inc. INGN incurred an adjusted loss per share of 2 cents for third-quarter 2025, which was narrower than the adjusted loss per share of 11 cents in the year-ago period and the Zacks Consensus ...

It has been about a month since the last earnings report for Inogen (INGN). Shares have lost about 0.6% in that time frame, underperforming the S&P 500. But investors have to be wondering, will the ...

BEVERLY, Mass.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that Kevin Smith, ...

Inogen’s share price has performed poorly since I rated the stock a Buy in July 2023, and for good reason. Another round of senior executive changes combined with a questionable acquisition has ...